China Gold Supplier for Canagliflozin Prescribing Information - Rosuvastatin Calcium – CPF
China Gold Supplier for Canagliflozin Prescribing Information - Rosuvastatin Calcium – CPF Detail:
瑞舒伐他汀钙 | Rosuvastatin Calcium | 147098-20-2 | In-House/CEP |
RSM(Crystal) | 147118-40-9 | In-House | |
RSM(Crude) | 147118-40-9 | In-House | |
RSP | — | In-House | |
RS-8 | 147118-36-3 | In-House | |
RS-8-1 | 147118-37-4 | In-House | |
TP-8 | 131466-61-0 | In-House | |
TP-11 | 147118-35-2 | In-House | |
TP-13 | 147118-39-6 | In-House | |
RS-10 | 289042-12-2 | In-House | |
RS-11 | 355806-00-7 | In-House |
Description
Rosuvastatin Calcium (BANM, JAN, USAN) is known as Rosuvastatin in the US. and a competitive HMG-CoA reductase inhibitor with an IC50 of 11 nM[1]. Rosuvastatin Calcium potently blocks human ether-a-go-go related gene (hERG) current with an IC50 of 195 nM, delayed cardiac repolarization, and thereby prolonged action potential durations (APDs) and corrected QT interval (QTc) intervals[2]. Rosuvastatin Calcium reduces the expression of the mature hERG and the interaction of heat shock protein 70 (Hsp70) with the hERG protein. Rosuvastatin Calcium is very effective in lowering low-density lipoprotein (LDL) cholesterol, triglycerides, and C-reactive protein levels[3].
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
In the US, Rosuvastatin (rosuvastatin systemic) is a member of the drug class statins and is used to treat Atherosclerosis, High Cholesterol, High Cholesterol – Familial Heterozygous, High Cholesterol – Familial Homozygous, Hyperlipoproteinemia, Hyperlipoproteinemia Type IIa – Elevated LDL, Hyperlipoproteinemia Type IIb – Elevated LDL VLDL, Hyperlipoproteinemia Type III – Elevated beta-VLDL IDL, Hyperlipoproteinemia Type IV – Elevated VLDL, Hypertriglyceridemia and Prevention of Cardiovascular Disease.
Background
A selective, competitive inhibitor of HMG-CoA reductase, that is also antilipemic.
Storage
Powder |
-20°C |
3 years |
4°C |
2 years | |
In solvent |
-80°C |
6 months |
-20°C |
1 month |
Chemical structure
Proposal 18 Quality Consistency Evaluation projects which have approved 4, and 6 projects are under approving.
Advanced international quality management system has laid solid foundation for sales.
Quality supervision runs through the whole life cycle of the product to ensure the quality and therapeutic effect.
Professional Regulatory Affairs team supports the quality demands during the application and registration.
VIEW MORE
VIEW MORE
International cooperation
Domestic cooperation
Product detail pictures:
Related Product Guide:
Assume full obligation to meet all demands of our customers; accomplish ongoing advancements by promoting the advancement of our customers; become the final permanent cooperative partner of clientele and maximize the interests of shoppers for China Gold Supplier for Canagliflozin Prescribing Information - Rosuvastatin Calcium – CPF , The product will supply to all over the world, such as: Denmark, Sri Lanka, Madagascar, Our advantages are our innovation, flexibility and reliability which have been built during last 20 years. We focus on providing service for our clients as a key element in strengthening our long-term relationships. The continual availability of high grade products in combination with our excellent pre- and after-sales service ensures strong competitiveness in an increasingly globalized market.
By Jo from Istanbul - 2017.12.09 14:01
As a veteran of this industry, we can say that the company can be a leader in the industry, select them is right.
By Freda from Poland - 2018.10.01 14:14